Header Logo

Connection

HUGO VILLANUEVA to Urinary Bladder Neoplasms

Back to Details
This is a "connection" page, showing publications HUGO VILLANUEVA has written about Urinary Bladder Neoplasms.
HUGO VILLANUEVA
Connection Strength
0.381
Urinary Bladder Neoplasms
  1. Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer. Cell Rep Med. 2025 Aug 19; 6(8):102255.
    View in: PubMed
    Score: 0.166
  2. Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene. 2020 10; 39(40):6265-6285.
    View in: PubMed
    Score: 0.109
  3. Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Clin Cancer Res. 2019 06 15; 25(12):3689-3701.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.